2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

Embed Size (px)

Citation preview

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    1/40

    Heru Pranata (090100073)

    Rio Nurdiansyah Batubara

    (090100173)

    Supervisor : dr. Yazid Dimyati,

    Sp.A(K)

    Nephrotic Syndrome

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    2/40

    Definition

    Proteinuria(>40mg/m2/h)

    Hypoalbuminemia

    Hypercholesterolemia

    Edema

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    3/40

    AethiologyA. Genetic disorders Nephrotic-syndrome

    typical

    Proteinuira with or

    without nephroticsyndrome

    Multisystem syndromeswith or withoutnephrotic syndrome

    Metabolic disorderswith or withoutnephrotic syndrome

    Idiopathic nephrotic

    syndrome

    B. Secondary causes

    Infections

    Drugs

    Immunological orallergic disorders

    Associated withmalignant disease

    Glomerularhyperfiltration

    C. Congenital nephroticsyndrome

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    4/40

    Also known as lipoidnephrosis or nil

    disease

    It refers to a

    histopathologic lesion

    in the glomerulus

    Disorder of T cells,

    which release a

    cytokine that injures

    the glomerular

    epithelial foot

    processes.

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    5/40

    A viral- or toxin-mediated damage or

    intrarenal

    hemodynamic

    changes such ashyperperfusion and

    high intraglomerular

    capillary pressure

    1. Injury to podocytes

    2. shrinkage/collapse

    of glomerular

    capillaries

    3. scarring

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    6/40

    Pathophysiology

    Proteinuria

    Hypoalbuminemi

    a

    Hypercholesterole

    mia

    Oedem

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    7/40

    Pathophysiology

    Glomerular filtration process in interrupted

    Commonly a defect in the podocytes and/or

    glomerular basement membrane.

    Recent experiments have implicated T-Cells inthe damage to podocytes leading to 2 common

    types of nephrotic syndrome (minimal change

    disease and focal-segmental glomerulosclerosis)

    Exact pathology varies depending on the specifictype of nephrotic syndrome.

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    8/40

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    9/40

    Pathophisiology

    HYPERCHOLESTROLEMIA.Response toHypoalbuminemia reflex to liver-- synthesis

    of generalize protein ( including lipoprotein )

    and lipid in the liver ,the lipoprotein high

    molecular weight no loss in urine hyperCHOLESTROLEMIA

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    10/40

    Pathophisiology

    *Reduction plasma colloid oncoticpressure secondary to hypoalbuminemiaOEdema and hypovolemia

    *Intravascular volume antidiuretic hormone(ADH ) and aldosterone(ALD) water andsodium retentionOEdema

    *Intravascular volume glomerular filtrationrate

    (GFR) water and sodium retentionOEdema

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    11/40

    CLINICAL MANIFESTATIONS

    Proteinuria

    Hypoalbuminemia

    Generalized Oedema

    Hyperlipidemia

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    12/40

    Diagnose

    Anamnesis

    Laboratory Evaluation

    - Urine Test

    -Albumin Level

    -Renal Function test

    Renal Biopsy

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    13/40

    Indication for Renal Biopsy

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    14/40

    Differential Diagnosis

    Nephritic Syndrome

    Non Renal Disease

    -CHF

    -Nutrition Imbalance-Hepatic oedema

    -Acute Glomerulonephritis

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    15/40

    Remision Urine albumin nil or trace (or proteinuria

    < 4 mg/m2/h) for 3 consecutive early

    morning specimens

    Relapse Urine albumin 3+ or 4+ ( or proteinuria >40mg/m2/h) for 3 consecutive early

    morning specimens, having been in

    remission peviously

    Frequents Relapses Two or more relapses in initial six months

    or more than three relapses in any twelve

    months

    Steroid Dependence Two consecutive relapses when or

    alternate day steroids or within 14 days of

    its discontinuation

    Steroid Resistance Absence of remission despite therapy with

    daily prednisone at dose of 2 mg/kg per

    day for 4 weeks

    Infrequent s Resistance relapses occurred less than 2 times in the

    first 6 months after initial response or less

    than 4 times per year of observation

    Steroid Sensitive remission is achieved in 4 weeks or less

    after full-dose steroid treatment

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    16/40

    Treatment Initial

    60 mg/m2/day for 4 weeks (maximum 80 mg)

    40 mg/m2/on alternate days for 4 weeks (maximum

    60mg)

    Reduce dose by 5-10mg/m2 each week for another 4

    weeks then stop

    If If prednisolone causes gastric irritation, start

    ranitidine 2mg/kg bid for the duration of steroid

    treatment

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    17/40

    continous

    Albumin

    Penicilin Prophylaxis

    Salt / Fluid Restriction

    Vaccination

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    18/40

    Treatment

    Relapsing Infrequent Relapsing Frequent

    Prednisone or prednisolone -

    start at 60mg/ m2/day (max

    80mg) until in remission

    Then give alternate day

    prednisone or prednisolone at

    40mg/ m2/day (max 60mg) fortotal of 28 days, then stop

    Low Dose Alternate

    Day Prednisolone

    Levamisole

    Cyclophosphamide

    Cyclosporin

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    19/40

    Nephrotic Syndrome Resistant

    Steroid

    Prednisone 40 mg/m2LPB/day tapering off prednisone

    at a dose of 1 mg / kg / day for 1 month, followed by

    0.5 mg / kg / day for 1 month (long tapering off 2

    months)

    cyclophosphamide 2-3 mg / kg / day single dose for 3-

    6 months

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    20/40

    Supportive Care

    Diet Edema

    Adequate in protein

    (1,5-2g/kg)

    reduction of salt intake

    (1-2 g per day) is

    advised for those with

    persistent edema

    Patients with persisten

    edema and weight gain of 7-

    10 % are treated with oral

    furosemide (1-3 mg/kg,

    daily).

    potassium sparing diuretics,e.g. spironolactone (2-4

    mg/kg daily)

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    21/40

    Hypovolaemia

    Despite odema may be intra-vascularly depleted

    Infection Loss of complement components

    Thrombosis

    Loss of proteins and exacerbated by hypovolaemia

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    22/40

    Prognose

    MINIMAL CHANGE PATHOLOGY :- GOOD PROGNOSIS

    FOCAL SEGMENTAL

    GLOMERULARSCLEROSIS :-

    PROGNOSIS IS GRAVE

    END STAGE IS LIKELY TO HAPPEN

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    23/40

    CASE REPORT

    Name : JS

    Age : 9 years

    Sex : Male

    Date of Admission : August, 21th

    2013

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    24/40

    Main Complaint : Swelling on the eyelids

    History : Swelling on the eyelids had been complained by the patient in

    2 days before admitted to the hospital. Swelling on the eyelids became

    worst in 2 days. Patient also complain that his urine output became

    lesser in 2 days. History of waists pain was not found. Fever was notfound, Unclear urine was complained by patient since yesterday.

    Painful urinating was not suffered by patient.

    History of body swelling had been suffered by patient since 2 months

    ago. Patient had been treated before in Sidikalang Hospital for 3 days

    and was diagnosed by nephrotic syndrome by pediatrician. Patient wasunder treatment of steroid for 4 weeks, but patient didnt get remission.

    Then, patient was diagnosed nephrotic syndrome resistant steroid and

    treated by cyclophosphamide and prednisone. After that patient was

    consuled to Adam Malik General Hospital

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    25/40

    History of Immunization: Not Clear

    History of birth : Not Clear

    History of immunization : Not Clear

    History of Growth and Development : Not clear

    History of Illness : Not clear

    History of Medication : Not clear

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    26/40

    Physical Examination

    BW: 30 kg ; BL: 127 cm cm

    Presens status

    Sensorium : Compos Mentis, Blood Pressure : 100/70 mmHg,

    Body temperature: 36,8oC, Pulse: 100 bpm, Respiratory Rate:

    20 bpm.

    Localized status

    Head : Eyes : Light reflexes(+/+), isochoric pupil, pale

    conjunctiva palpebra inferior (-/-), preorbital oedem (+/+),

    icteric (-/-) , Ear : Normal appereance ,Mouth : Sianosis (-),

    Nose: Normal appereance.

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    27/40

    Neck : Lymph node enlargement (-), nuchal rigidity (-)

    Thorax : Symmetrical fusiformis, retraction (-).

    HR: 88 bpm, reguler, murmur (-).

    RR: 26 bpm, regular, crackles (-/-)

    Abdomen : Soepel, peristaltic (+) normal. Liver and spleen not palpable

    Extremities : Pulse 88 bpm, regular, adequate pressure and volume warm

    acral, CRT < 3, TD: 100/70 mmhg, pitting oedem(+/+).

    Differential Diagnosis

    Steroid Resistance Nephrotic Syndrome

    Relaps Nephrotic Syndrome

    Nutrition Imbalance

    Working Diagnosis

    Steroid Resistance Nephrotic Syndrome

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    28/40

    Treatment

    Threeway

    Normal diet low salt with 60gr protein and 1900Kcalories

    Captopril 2x25 mg

    Losartan 1x0,5 tab

    Prednison 1x7 mg

    Inj. Ceftriaxone 1 gr/12h/IV Inj. Furosemide 30 mg/8h

    Aldacton 3x25 mg

    Planning

    Serial Urinalisis Fluid Balance per 6 hours

    Renal Function Test

    Renal Biopsy

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    29/40

    Laboratory Result (August 21th 2013)

    Complete Blood

    Count

    Result Normal Range

    Hemoglobin (HGB) g% 10.50 11.314.1

    Eritrosit (RBC) 106/ mm3 3.39 4.404.48

    Leukosit (WBC) 103

    / mm3

    6640 4.5- 13.5

    Hematokrit % 29.00 3741

    Trombosit (PLT) 103/ mm3 633000 217497

    MCV fL 85,50 8195

    MCH Pg 31.00 2529

    MCHC g% 36.20 2931

    RDW % 13.70 11.614.8

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    30/40

    Diftel Result Normal Range

    Neutrofil % 62,70 3780

    Limfosit % 20,80 2040

    Monosit % 14,60 28

    Eosinofil % 0.50 16

    Basofil % 1200 01

    Neutrofil Absolut 103/L 4.17 2.4 - 7.3

    Limfosit Absolut 103

    /L 1,38 1.7 - 5.1

    Monosit Absolut 103/L 0.97 0.2 - 0.6

    Eosinofil Absolut 103/L 0.03 0.10 - 0.30

    Basofil Absolut 103/L 0.09 0 - 0.1

    Electrolyte

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    31/40

    Electrolyte

    Electrolyte Result Normal Range

    Natrium( Na) mEq/L 130 135-155

    Kalium (K) mEq/L 5.1 3.6-5.5

    Cloride (Cl) mEq/L 107 96-106

    Hepar

    Albumin g/dl 1,6 3,8-5,4

    Kidney

    Ureum mg/dL 91.10

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    32/40

    Urinalisis Result

    Colour Kuning keruh

    Glucose -

    Bilirubin -

    Keton -

    Berat Jenis 1015

    PH 5

    Protein +++

    Urobilinogen -

    Nitrit -

    Blood -

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    33/40

    Sedimen Result

    Eritrocyte 0-2

    Leukocyte 25-30

    Ephitel 1-2

    Casts Granular

    Crystal -

    August, 21th 2013 (First day)

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    34/40

    g , ( y)

    S:Swelling on the face and foot

    O: Sens: Compos Mentis , Temp: 37oC, Body weight: 30kg

    Head Eye : Light reflexes(+/+), isochoric pupil, pale conjunctiva palpebra inferior(-/-).Neck : Lymph node enlargement (-), nuchal rigidity (-)Ear/Mouth/Nose: normal

    Thorax Symmetrical fusiformis. Epigastrial retraction (-). HR: 88 bpm,reguler, murmur (-). RR: 28 bpm,regular,crackles (-/-)

    Abdomen Soepel,Peristaltic (+) Normal. Liver and spleen not palpableExtremities Pulse 88 bpm, regular, adequate pressure and volume, warm acral, CRT 40mg/kgbb/day),

    hypoalbunemia (200mg/dl) and also proof of oedema. In

    this patient all of the characteristic symptomps was found. Proteinuria (+++) which mean that

    the protein loss is 300mg/dL, hypoalbuminemia 1,6mg/dL (N: 3,85,4) as the consequences of

    protein loss from urine. Oedem was found in preorbital and pretibial area.

    Hypercholesterolemia were unknown because it was not checked.

    According to anamnesis, the patient has been treated about 2 months ago and diagnosed by

    nephrotic syndrome. The patient had full dose steroid for 4 weeks, but the patient still not have

    remission. For now, the patient came back with oedem preorbital and still not have remission.

    After that, the patient diagnosed by Steroid Resistant Nephrotic Syndrome because of the

    patient was not have remission after steroid therapy.

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    38/40

    DISCUSSION The patient was given diuretic (furosemide and spironolactone) to treat

    fluid retention that cause oedem on this patient. Then captopril and

    losartan has given to this patient to avoid renal hypertension and

    cardiac remodeling. Prednisone still given to wait to cyclophosphamide

    ready to be administrated to this patient for steroid resistant nephrotic

    syndrome therapy to prevent genetic mutation as cytostatic and

    imunosupressan. Ceftriaxone injection was given as profilaxis to

    nosocomial infection.

    A low salt diet and high protein has been given to the patient to prevent

    further fluid retention and oedem.

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    39/40

    SUMMARY

    JS, 9 years old male diagnosed with SteroidResistent Nephrotic Syndrome and treated

    byThree way,Diet MB low salt with 60 gr protein

    and 1900 calories, Inj. Ceftriaxone 1gr/12 hours,

    Inj. Lasix 30 mg/ 8 hours, Aldacton 3 x 25 mg,Captopril 2 x 25 mg, Losartan 1 x 0,5 tab,

    Prednison 1x 7 mg AD

  • 7/29/2019 2 Sindroma Nefrotik Pesentasi Lapkas Heru Rio

    40/40

    Thank you